What changes are needed for more connected and continuous manufacturing?
Biopharma manufacturers continue to evaluate opportunities to improve process performance across downstream unit operations.
Archives for January 19, 2022
De-risking cell therapy manufacturing with downstream technology innovation
Automated cell therapy manufacturing processes could reduce manual intervention and human errors, enabling more robust processes, improved product quality, and lower costs.
Researchers set out novel anion exchange membrane chromatography method for separating empty and full adeno-associated virus
Adeno-associated virus (AAV) hold potential for use in numerous gene therapies: with demand only set to grow as more therapies are developed and approved. However, supply of AAV is one of the challenges for the sector. In a study published in...
Downstream biomanufacturing set for high growth over the next decade
Downstream biomanufacturing is expected to witness a high CAGR over the next 10 years: driven by continuous product innovations in chromatography product lines and filtration systems.